This Article Full Text Full Text (PDF) All Versions of this Article: 39/4/1340    most recent STROKEAHA.107.500132v1 Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Request Permissions Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Han, J. H. Articles by Wong, K. S. Search for Related Content PubMed PubMed Citation Articles by Han, J. H. Articles by Wong, K. S. Related Collections Brain Circulation and Metabolism Other Stroke Treatment - Medical

(Stroke. 2008;39:1340.)
© 2008 American Heart Association, Inc.

Research Letters

Preliminary Findings of External Counterpulsation for Ischemic Stroke Patient With Large Artery Occlusive Disease

Jing Hao Han, MD; Thomas W. Leung, MD; Wynnie W. Lam, MD; Yannie O. Soo, MD; Anne W. Alexandrov, PhD; Vincent Mok, MD; Yee-Fong V. Leung, PhD; Raymond Lo, MD Ka Sing Wong, MD

From Department of Medicine and Therapeutics (J.H.H., T.W.L., Y.O.S., V.M., K.S.W.), Chinese University of Hong Kong, Hong Kong; Department of Neurology (J.H.H.), Huashan Hospital, Fudan University, Shanghai, China; Department of Diagnostic Radiology and Organ Imaging (W.W.L., Y.-F.V.L.), Chinese University of Hong Kong, Hong Kong; University of Alabama (A.W.A.), Birmingham, Ala; Department of Medicine (R.L.), Shatin Hospital, Hong Kong.

Correspondence to Dr Ka Sing Wong, Department of Medicine and Therapeutics, Prince of Wales Hospital, Shatin, Hong Kong. E-mail ks-wong{at}cuhk.edu.hk

Abstract

Background and Purpose— We aimed to investigate the feasibility and therapeutic effect of external counterpulsation (ECP) in ischemic stroke.

Methods— The trial was a randomized, crossover, assessment-blinded, proof-of-concept trial. ECP treatment consisted of 35 daily 1-hour sessions. Patients were randomized to either early (ECP weeks 1 to 7 and no ECP weeks 8 to 14) or late group (no ECP weeks 1 to 7 and ECP weeks 8 to 14). Primary outcomes were an overall change in National Institutes of Health Stroke Scale (NIHSS) and cerebral blood flow estimated by color velocity imaging quantification. Secondary outcomes were change in NIHSS, color velocity imaging quantification, favorable functional outcome (modified Rankin scale, 0 to 2), and stroke recurrence at weeks 7 and 14, respectively.

Results— Fifty patients were recruited. At week 7, there was a significant change in NIHSS (early 3.5 vs late 1.9; P=0.042). After adjusting for treatment sequence, ECP was associated with a favorable trend of change in NIHSS of 2.1 vs 1.3 for non-ECP (P=0.061). Changes of color velocity imaging quantification were not significant but tended to increase with ECP. At week 14, a favorable functional outcome was found in 100% of early group patients compared to 76% in the late group (P=0.022).

Conclusion— ECP is feasible for ischemic stroke patients with larger artery disease.

Key Words: cerebral blood flow • counterpulsation • stroke

This article has been cited by other articles:

				P. B. Gorelick, K. S. Wong, H.-J. Bae, and D. K. Pandey Large Artery Intracranial Occlusive Disease: A Large Worldwide Burden but a Relatively Neglected Frontier Stroke, August 1, 2008; 39(8): 2396 - 2399. [Abstract] [Full Text] [PDF]